SPOTLIGHT: Making the case for pharma-doctor friendship

While some critics would vigorously dispute the idea, a representative of the pharma industry is arguing that its close relationships with physicians are actually good for the industry. Pharma outreach to physicians makes sure that the physicians get the latest information on drugs from the companies that know the drugs' strengths and weaknesses best, which helps keep prescribing safe, says Scott Lassman, senior assistant general counsel for the Pharmaceutical Research and Manufacturers of America. Editorial

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.